ADHD Pre-Test (Optional)
1. Which of the following medications is not approved for clinical use in the treatment of ADHD:
a. Atomoxetine
b. Guanfacine
c. Methylphenidate
d. Bupropion
e. Amphetamine
2. If a patient’s medical history is unremarkable and there are no clinical signs of a learning disorder, which laboratory and psychological/neuropsychological tests are recommended as part of the assessment for ADHD?
a. Baseline height and Weight
b. Thyroid Studies
c. Electroencephalogram
d. Head CT or MRI
e. Neuropsychological or Psychological evaluation
3. Which is the best initial pharmacologic treatment for children and adolescents with ADHD?
a. A preparation of medication containing Methylphenidate
b. A preparation of medication containing Amphetamine
c. Atomoxetine
d. A preparation of medication containing Tricyclic Antidepressant
e. Any medication approved by the FDA for the treatment of ADHD may be used as the initial pharmacologic treatment
4. If several standard treatments for ADHD are not effective, which of the following are not recommended as next steps in the treatment of the patient?
a. Reassess the diagnosis
b. Reassess for comorbid psychiatric disorders
c. Recommend behavioral therapy
d. Consideration of second line, off-label medication treatments for ADHD (which may include bupropion, tricyclic antidepressant, modafinil, guanfacine and clonidine) as well as combination therapy
e. Concluding that If standard FDA approved treatments do not work then the patient does not have ADHD
5. Considering recent data about the development of Substance Use Disorders in ADHD patients which if the following is true?
a. The Gateway theory is supported
b. Extended delivery stimulants are more likely to be abused than immediate release stimulants
c. Most adolescents with ADHD will abuse their medication for ADHD
d. Although diversion and misuse of ADHD medications is a serious problem that warrants discussion with families, most adolescents with ADHD will not abuse/misuse their medication for ADHD